mTOR signalling, which appears to be increased in late-stage AD brains compared to controls (Griffin et al., 2005; Li et al., 2005; Sun et al., 2014), is regulated by growth factors, nutrients, energy levels and stress. The gene discussed is MTOR; the disease is Alzheimer disease.